-
公开(公告)号:EP2742356B1
公开(公告)日:2016-04-27
申请号:EP12754124.1
申请日:2012-08-08
发明人: RICCI, Deborah , LI, Weimin , HENITZ, Erin, Devay
IPC分类号: G01N33/574
CPC分类号: C12Q1/6886 , A61K31/19 , A61K31/196 , A61K31/198 , A61K31/573 , A61K31/69 , A61K39/39558 , G01N33/57407 , G01N33/92 , G01N2800/52 , A61K2300/00
-
公开(公告)号:EP2742356A1
公开(公告)日:2014-06-18
申请号:EP12754124.1
申请日:2012-08-08
发明人: RICCI, Deborah , LI, Weimin , HENITZ, Erin, Devay
IPC分类号: G01N33/574
CPC分类号: C12Q1/6886 , A61K31/19 , A61K31/196 , A61K31/198 , A61K31/573 , A61K31/69 , A61K39/39558 , G01N33/57407 , G01N33/92 , G01N2800/52 , A61K2300/00
摘要: The present invention provides methods of predicting a response to a cancer treatment by determining CD68 level or PSMBl (PI 1A) polymorphism in a biological sample and the presence or quantity of a second biomarker in the patient. The invention also provides kits and methods for treating cancer.
-
3.BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE 审中-公开
标题翻译: 生物标志物鉴定缬氨酸UR UNG UNG UNG UNG AT AT AT AT AT AT AT AT AT AT AT公开(公告)号:EP3143156A1
公开(公告)日:2017-03-22
申请号:EP15723409.7
申请日:2015-05-07
发明人: SOKOL RICCI, Deborah , LI, Weimin , GORMLEY, Michael , KARKERA, Jayaprakash , SCHAFFER, Michael
IPC分类号: C12Q1/68
摘要: Provided herein are methods of predicting a likelihood of survival following treatment with AA and prednisone in a patient having CRPC.
摘要翻译: 本文提供了在具有CRPC的患者中用AA和强的松治疗后预测存活可能性的方法。
-
-